γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers

Nuša Trošt, Samuel Peña-Llopis, Sajjan Koirala, Jurij Stojan, Patrick Ryan Potts, Klementina Fon Tacer, Elisabeth D. Martinez

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Over the last decade, breast cancer mortality has declined. However, triple negative breast cancer (TNBC) remains a challenging problem mostly due to early recurrence and lack of molecularly driven treatments. There is a critical need to identify subgroups of TNBC with common molecular features that can be therapeutically targeted. Here we show that in contrast to Klotho and βKlotho, the third member of the Klotho protein family, γKlotho, is overexpressed in more than 60% of TNBCs and correlates with poorer disease progression. Furthermore, we find that γKlotho is expressed in a subset of TNBC cell lines promoting cell growth. Importantly, we demonstrate that in these cells γKlotho is necessary for cell survival and that its depletion leads to constitutive ERK activation, cell cycle arrest and apoptosis. Interestingly, we observe increased oxidative stress in γKlotho-depleted cells suggesting that γKlotho enables cancer cells to cope with an oxidative environment and that cells become dependent on its expression to maintain this survival advantage. These findings indicate that γKlotho might be a potential marker for patients that would benefit from treatments that alter oxidative stress and constitutes a novel drug target for a subset of TN breast cancers.

Original languageEnglish (US)
Pages (from-to)2611-2628
Number of pages18
JournalOncotarget
Volume7
Issue number3
DOIs
StatePublished - 2016

Keywords

  • Cancer therapy
  • FGF
  • Klotho
  • Oxidative stress
  • TNBC

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers'. Together they form a unique fingerprint.

  • Cite this

    Trošt, N., Peña-Llopis, S., Koirala, S., Stojan, J., Potts, P. R., Tacer, K. F., & Martinez, E. D. (2016). γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers. Oncotarget, 7(3), 2611-2628. https://doi.org/10.18632/oncotarget.6006